Anita Sarma

560 total citations
11 papers, 87 citations indexed

About

Anita Sarma is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Anita Sarma has authored 11 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 3 papers in Immunology. Recurrent topics in Anita Sarma's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Anita Sarma is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Anita Sarma collaborates with scholars based in United Kingdom, United States and Italy. Anita Sarma's co-authors include Anita Mukherjee, Amit Chakrabarti, McDonald K. Horne, Debasri Mukherjee, T. Banerjee, James P. Dean, Tadeusz Robak, Paul M. Barr, Paolo Ghia and Jan A. Burger and has published in prestigious journals such as Blood, Cancer Letters and Food and Chemical Toxicology.

In The Last Decade

Anita Sarma

7 papers receiving 86 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anita Sarma United Kingdom	5	28	15	13	13	12	11	87
Claire Cadeau France	6	5 0.2×	4 0.3×	3 0.2×	6 0.5×	1 0.1×	9	118
Sophia Tsabouri France	8	3 0.1×	3 0.2×		8 0.6×	3 0.3×	33	196
Zipu Li China	5	2 0.1×	22 1.5×		6 0.5×	10 0.8×	12	186
Mohammed Ali Nigeria	6		4 0.3×	6 0.5×	8 0.6×	5 0.4×	13	91
Huiling Xiang China	8		8 0.5×		16 1.2×	13 1.1×	22	220
King Fai Cheng Hong Kong	7	1 0.0×	3 0.2×	3 0.2×	10 0.8×	16 1.3×	9	158
Reza Faridhosseini Iran	8	1 0.0×	9 0.6×		11 0.8×	6 0.5×	23	190
Ewa Trębas-Pietraś Poland	6		3 0.2×	2 0.2×	3 0.2×	14 1.2×	10	325
Paula Cerdá Spain	4	1 0.0×	15 1.0×		3 0.2×	4 0.3×	10	95
Robert Leverette United States	8	3 0.1×	3 0.2×	2 0.2×	24 1.8×		18	342

Countries citing papers authored by Anita Sarma

Since Specialization

Citations

This map shows the geographic impact of Anita Sarma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Sarma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Sarma more than expected).

Fields of papers citing papers by Anita Sarma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Sarma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Sarma. The network helps show where Anita Sarma may publish in the future.

Co-authorship network of co-authors of Anita Sarma

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Sarma. A scholar is included among the top collaborators of Anita Sarma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Sarma. Anita Sarma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Sharief, M. K., et al.. (2025). Haemophagocytic lymphohistiocytosis (HLH) with concurrent Hodgkin’s Disease. BMJ Case Reports. 18(3). e261944–e261944.

Rawstron, Andy C., David Cairns, Nichola Webster, et al.. (2025). Optimising MRD-guided treatment: UMRD4 as a half-way treatment timepoint for ibrutinib-venetoclax substantially delays MRD relapse after end of treatment in both IGHV-mutated and IGHV-unmutated CLL.. Blood. 146(Supplement 1). 794–794.

Sarma, Anita & Piers Patten. (2025). Chronic lymphocytic leukaemia. Medicine. 53(5). 298–303.

Burger, Jan A., Paul M. Barr, Tadeusz Robak, et al.. (2025). Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL. Blood. 146(18). 2168–2176. 5 indexed citations

Dalal, Surita, Darren Newton, Nichola Webster, et al.. (2025). Acquired Bruton's tyrosine kinase mutations in patients treated on the ibrutinib and rituximab, ibrutinib alone, and ibrutinib and venetoclax arms of the national multi-centre Phase III FLAIR study in previously untreated CLL patients. Blood. 146(Supplement 1). 796–796.

Burger, Jan A., Paul M. Barr, Tadeusz Robak, et al.. (2024). CLL-076 Final Analysis of the RESONATE-2 Study: up to 10 Years of Follow-Up of First-Line Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 24. S342–S343. 4 indexed citations

Burger, Jan A., Paul M. Barr, Tadeusz Robak, et al.. (2024). Final Analysis of the RESONATE-2 Study: Up to 10 Years of Follow-Up of First-Line Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 24. S179–S179. 5 indexed citations

Rawstron, Andy C., Nichola Webster, Surita Dalal, et al.. (2023). Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. Blood. 142(Supplement 1). 632–632. 1 indexed citations

Sarma, Anita & McDonald K. Horne. (2006). Venlafaxine‐induced ecchymoses and impaired platelet aggregation. European Journal Of Haematology. 77(6). 533–537. 16 indexed citations

10.

Sarma, Anita, et al.. (1992). Evaluation of pan masala for toxic effects on liver and other organs. Food and Chemical Toxicology. 30(2). 161–163. 33 indexed citations

11.

Mukherjee, Anita, et al.. (1991). Effect of ‘Pan Masala’ on the germ cells of male mice. Cancer Letters. 58(3). 161–165. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact